Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Forte Biosciences PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| October 02, 2026 |
PE Ratio Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| argenx SE | 35.03 |
| ACADIA Pharmaceuticals, Inc. | 8.985 |
| Alnylam Pharmaceuticals, Inc. | 37.10 |
| Savara, Inc. | -- |
| Vericel Corp. | 86.85 |
PE Ratio Related Metrics
| Price to Book Value | 8.580 |
| Price | 76.99 |
| Earnings Yield | -6.66% |
| Market Cap | 1.577B |